Entellus Medical

Investor Relations

We are a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of patients in the physician office setting or operating room who are suffering from chronic sinusitis. Our XprESS family of products is used by ear, nose and throat, or ENT, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses.
Stock Information
ENTL (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) + 0.10 (0.74%)
Data as of 05/26/17 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
Stock chart for: ENTL.O.  Currently trading at $13.59 with a 52 week high of $22.63 and a 52 week low of $11.47.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Recent NewsMore >>
05/22/17The Centers for Medicare & Medicaid Services (CMS) Establishes Coding and Payment for Eustachian Tube Balloon Dilation
05/03/17Entellus Medical Announces First Quarter 2017 Financial Results
04/20/17Entellus Medical to Present at the Deutsche Bank Annual Health Care Conference
04/19/17Entellus Medical to Report First Quarter 2017 Financial Results on May 3, 2017
Upcoming EventsMore >>
There are currently no events scheduled.